These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Macrophage-to-Myofibroblast Transition Contributes to Interstitial Fibrosis in Chronic Renal Allograft Injury. Wang YY; Jiang H; Pan J; Huang XR; Wang YC; Huang HF; To KF; Nikolic-Paterson DJ; Lan HY; Chen JH J Am Soc Nephrol; 2017 Jul; 28(7):2053-2067. PubMed ID: 28209809 [TBL] [Abstract][Full Text] [Related]
43. [The effect of transforming growth factor β(1) in the transition of bone marrow-derived macrophages into myofibroblasts during renal fibrosis]. Yang Y; Feng XJ; Liu XY; Wang LH; Zheng GP Zhonghua Nei Ke Za Zhi; 2017 Aug; 56(8):610-613. PubMed ID: 28789496 [TBL] [Abstract][Full Text] [Related]
44. Instructive Role of the Microenvironment in Preventing Renal Fibrosis. Matsumoto K; Xavier S; Chen J; Kida Y; Lipphardt M; Ikeda R; Gevertz A; Caviris M; Hatzopoulos AK; Kalajzic I; Dutton J; Ratliff BB; Zhao H; Darzynkiewicz Z; Rose-John S; Goligorsky MS Stem Cells Transl Med; 2017 Mar; 6(3):992-1005. PubMed ID: 28297566 [TBL] [Abstract][Full Text] [Related]
45. Silencing of microRNA-132 reduces renal fibrosis by selectively inhibiting myofibroblast proliferation. Bijkerk R; de Bruin RG; van Solingen C; van Gils JM; Duijs JM; van der Veer EP; Rabelink TJ; Humphreys BD; van Zonneveld AJ Kidney Int; 2016 Jun; 89(6):1268-80. PubMed ID: 27165825 [TBL] [Abstract][Full Text] [Related]
46. Blocking the class I histone deacetylase ameliorates renal fibrosis and inhibits renal fibroblast activation via modulating TGF-beta and EGFR signaling. Liu N; He S; Ma L; Ponnusamy M; Tang J; Tolbert E; Bayliss G; Zhao TC; Yan H; Zhuang S PLoS One; 2013; 8(1):e54001. PubMed ID: 23342059 [TBL] [Abstract][Full Text] [Related]
48. Immunohistochemical analysis of macrophages, myofibroblasts, and transforming growth factor-beta localization during rat renal interstitial fibrosis following long-term unilateral ureteral obstruction. Yamate J; Okado A; Kuwamura M; Tsukamoto Y; Ohashi F; Kiso Y; Nakatsuji S; Kotani T; Sakuma S; Lamarre J Toxicol Pathol; 1998; 26(6):793-801. PubMed ID: 9864097 [TBL] [Abstract][Full Text] [Related]
49. Delayed administration of hepatocyte growth factor reduces renal fibrosis in obstructive nephropathy. Yang J; Liu Y Am J Physiol Renal Physiol; 2003 Feb; 284(2):F349-57. PubMed ID: 12529273 [TBL] [Abstract][Full Text] [Related]
50. Inhibition of Fatty Acid-Binding Protein 4 Attenuated Kidney Fibrosis by Mediating Macrophage-to-Myofibroblast Transition. Feng Y; Guo F; Xia Z; Liu J; Mai H; Liang Y; Zhu G; Li Y; Bai L; Li L; Huang R; Shi M; Ma L; Fu P Front Immunol; 2020; 11():566535. PubMed ID: 33101287 [TBL] [Abstract][Full Text] [Related]
51. RIG-I aggravates interstitial fibrosis via c-Myc-mediated fibroblast activation in UUO mice. Zhou Z; Ni J; Li J; Huo C; Miao N; Yin F; Cheng Q; Xu D; Xie H; Chen P; Zheng P; Zhang Y; Zhou L; Zhang W; Yu C; Liu J; Lu L J Mol Med (Berl); 2020 Apr; 98(4):527-540. PubMed ID: 32036390 [TBL] [Abstract][Full Text] [Related]
52. MST1/2 in PDGFRα An Y; Ren Y; Wang J; Zang J; Gao M; Wang H; Wang S; Dong Y Am J Physiol Renal Physiol; 2022 May; 322(5):F512-F526. PubMed ID: 35253468 [TBL] [Abstract][Full Text] [Related]
53. Evidence of a Role for Fibroblast Transient Receptor Potential Canonical 3 Ca2+ Channel in Renal Fibrosis. Saliba Y; Karam R; Smayra V; Aftimos G; Abramowitz J; Birnbaumer L; Farès N J Am Soc Nephrol; 2015 Aug; 26(8):1855-76. PubMed ID: 25479966 [TBL] [Abstract][Full Text] [Related]
54. GSDMD-dependent neutrophil extracellular traps promote macrophage-to-myofibroblast transition and renal fibrosis in obstructive nephropathy. Wang Y; Li Y; Chen Z; Yuan Y; Su Q; Ye K; Chen C; Li G; Song Y; Chen H; Xu Y Cell Death Dis; 2022 Aug; 13(8):693. PubMed ID: 35941120 [TBL] [Abstract][Full Text] [Related]
55. Blockage of tubular epithelial to myofibroblast transition by hepatocyte growth factor prevents renal interstitial fibrosis. Yang J; Liu Y J Am Soc Nephrol; 2002 Jan; 13(1):96-107. PubMed ID: 11752026 [TBL] [Abstract][Full Text] [Related]
56. Glycogen synthase kinase-3 inhibition attenuates fibroblast activation and development of fibrosis following renal ischemia-reperfusion in mice. Singh SP; Tao S; Fields TA; Webb S; Harris RC; Rao R Dis Model Mech; 2015 Aug; 8(8):931-40. PubMed ID: 26092126 [TBL] [Abstract][Full Text] [Related]
57. Rapamycin ameliorates kidney fibrosis by inhibiting the activation of mTOR signaling in interstitial macrophages and myofibroblasts. Chen G; Chen H; Wang C; Peng Y; Sun L; Liu H; Liu F PLoS One; 2012; 7(3):e33626. PubMed ID: 22470459 [TBL] [Abstract][Full Text] [Related]
58. Protein arginine methyltransferase 1 mediates renal fibroblast activation and fibrogenesis through activation of Smad3 signaling. Zhu Y; Yu C; Zhuang S Am J Physiol Renal Physiol; 2020 Feb; 318(2):F375-F387. PubMed ID: 31813251 [TBL] [Abstract][Full Text] [Related]
59. IFN Regulatory Factor 4 Controls Post-ischemic Inflammation and Prevents Chronic Kidney Disease. Lorenz G; Moschovaki-Filippidou F; Würf V; Metzger P; Steiger S; Batz F; Carbajo-Lozoya J; Koziel J; Schnurr M; Cohen CD; Schmaderer C; Anders HJ; Lindenmeyer M; Lech M Front Immunol; 2019; 10():2162. PubMed ID: 31632388 [TBL] [Abstract][Full Text] [Related]
60. Tubule-derived INHBB promotes interstitial fibroblast activation and renal fibrosis. Sun Y; Cai H; Ge J; Shao F; Huang Z; Ding Z; Dong L; Chen J; Zhang J; Zang Y J Pathol; 2022 Jan; 256(1):25-37. PubMed ID: 34543458 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]